| Q34700305 | An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia |
| Q58493466 | Approaches to dyslipidemia treatment in children and adolescents |
| Q37732240 | Atherosclerosis prevention and treatment in children and adolescents |
| Q87393561 | Chapter 4: Pharmacological cholesterol-lowering treatment in children |
| Q61812327 | Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment |
| Q52016106 | Cholesterol homeostasis in development: the role of Xenopus 7-dehydrocholesterol reductase (Xdhcr7) in neural development. |
| Q50895846 | Cholesterol screening and management in children and young adults should start early--NO! |
| Q88956382 | Cholesterol screening and statin use in children: a literature review |
| Q43065808 | Cholesterol screening in children: makes sense but what is the impact? |
| Q37629709 | Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention |
| Q37152937 | Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model |
| Q33924782 | Long-term pharmacotherapy for elevated low density lipoprotein levels in children: A retrospective analysis |
| Q34417480 | Optimal management of familial hypercholesterolemia: treatment and management strategies |
| Q35799689 | Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years |
| Q28068014 | Pediatric Statin Administration: Navigating a Frontier with Limited Data |
| Q38049379 | Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children |
| Q36965617 | Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review. |
| Q93609057 | References |
| Q58772783 | Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment? |
| Q58592693 | Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis |
| Q38660929 | Statin therapy across the lifespan: evidence in major age groups |
| Q24194816 | Statins for children with familial hypercholesterolemia |
| Q24234081 | Statins for children with familial hypercholesterolemia |
| Q38689931 | Statins for children with familial hypercholesterolemia |
| Q37384379 | Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects |
| Q35614311 | Therapeutic approach to FSGS in children |
| Q36300178 | Treatment of dyslipidemia in children and adolescents |
| Q51007698 | Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades. |
| Q34477252 | Use of statins for dyslipidemia in the pediatric population. |